
ClearPoint Neuro CLPT
$ 14.09
-7.06%
Quarterly report 2025-Q3
added 11-06-2025
ClearPoint Neuro Operating Expenses 2011-2026 | CLPT
Annual Operating Expenses ClearPoint Neuro
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 15.3 M | 12 M | 10.2 M | 10.8 M | 10.6 M | 10.3 M | 11.3 M | 9.98 M | 7.63 M | 9.08 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 15.3 M | 7.63 M | 10.7 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | ||
|
Alphatec Holdings
ATEC
|
614 M | $ 13.94 | -0.71 % | $ 2.09 B | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
AxoGen
AXGN
|
121 M | $ 31.87 | 2.07 % | $ 1.47 B | ||
|
Cognyte Software Ltd.
CGNT
|
293 M | $ 7.0 | 5.74 % | $ 503 M | ||
|
EDAP TMS S.A.
EDAP
|
20.8 M | $ 4.38 | -4.58 % | $ 163 M | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Electromed
ELMD
|
40.3 M | $ 24.18 | 1.09 % | $ 204 M | ||
|
Aziyo Biologics
AZYO
|
41.6 M | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
53.7 M | $ 3.49 | 2.05 % | $ 121 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
Bio-Rad Laboratories
BIO
|
1.03 B | $ 275.33 | 2.19 % | $ 7.77 B | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
Bruker Corporation
BRKR
|
1.4 B | $ 40.88 | 2.48 % | $ 6.09 K | ||
|
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
10.2 B | $ 75.65 | 2.97 % | $ 112 B | ||
|
InMode Ltd.
INMD
|
136 M | $ 14.0 | 0.29 % | $ 905 M | ||
|
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.47 | -2.0 % | $ 23.7 M | ||
|
IRadimed Corporation
IRMD
|
34.4 M | $ 102.4 | 1.89 % | $ 1.3 B | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
CONMED Corporation
CNMD
|
648 M | $ 45.89 | -0.18 % | $ 1.42 B | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
LivaNova PLC
LIVN
|
697 M | $ 71.26 | 1.38 % | $ 3.89 B | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | ||
|
Medtronic PLC
MDT
|
15.3 B | $ 97.22 | 0.58 % | $ 125 B | ||
|
Delcath Systems
DCTH
|
43.4 M | $ 9.11 | -10.77 % | $ 260 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
60 M | $ 2.48 | 1.02 % | $ 146 M | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
126 M | - | - | $ 10.2 M | ||
|
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | ||
|
Establishment Labs Holdings
ESTA
|
160 M | $ 77.41 | -1.12 % | $ 2.18 B | ||
|
Insulet Corporation
PODD
|
531 M | $ 251.74 | 1.46 % | $ 17.7 B | ||
|
Quanterix Corporation
QTRX
|
120 M | $ 6.7 | 6.52 % | $ 252 M | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
FONAR Corporation
FONR
|
28.7 M | $ 18.53 | -0.3 % | $ 121 M | ||
|
Sintx Technologies
SINT
|
15.2 M | $ 2.89 | -1.87 % | $ 10.8 M | ||
|
MiMedx Group
MDXG
|
277 M | $ 4.97 | -5.78 % | $ 735 M |